“Receiving the CE mark approval for the product portfolio expansion enables physicians to treat a majority of patients presenting with ischemic stroke by utilizing low-profile technology for more efficient navigation and better aspiration.”
Abstract
Californian Ischemic Stroke treatment specialist MindFrame Inc. has announced that a CE mark has been granted for a new series of MindFrame Capture LP devices. Part of the comprehensive portfolio of MindFrame Therapy Solutions, the low profile devices have been expanded to include a 4 mm diameter and shorter length sizes.
Background
MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes for their patients.
The MindFrame Capture LP product portfolio can be uniquely deployed through smaller microcatheters to improve navigation through tortuous vessels. The MindFrame Capture LP 15mm device was expressly engineered to address treatment in short segments of tortuous vessels. Rapid flow restoration and clot retrieval is essential to prevent irreversible deterioration of brain function in patients suffering from acute ischemic stroke.
Compatible with any microcatheter 10/14 or greater, MindFrame LP devices provide clinicians with the additional benefit of increased thrombus aspiration when needed, both locally and proximally, as a result of the reduced microcatheter size. The devices offer improved tensile strength and kink resistance for device durability, as well as enhanced trackability for precise placement and control.
Company comments
“This represents another example of MindFrame’s commitment to rapid product development,” says Ken Charhut, president and CEO of MindFrame Inc. “Receiving the CE mark approval for the product portfolio expansion enables physicians to treat a majority of patients presenting with ischemic stroke by utilizing low-profile technology for more efficient navigation and better aspiration. MindFrame is committed to developing leading-edge devices that provide improved procedural and clinical outcomes for clinicians and their patients.”
MindFrame Capture LP is not approved for sale in the United States. Its representative in Europe is HealthLink Europe BV Centaurusweg 123 NL-5015 TC TILBURG The Netherlands
Source: Mindframeinc.com
published: January 9, 2012 in: Approval/Clearance, Launches / Withdrawals, Neuro, Regulatory